TY - JOUR
T1 - Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives
AU - Mattson, Mark P.
PY - 1997
Y1 - 1997
N2 - Amyloid precursor protein (β-APP), the source of the fibrillogenic amyloid β-peptide (Aβ) that accumulates in the brain of victims of Alzheimer's disease, is a multifunctional protein that is widely expressed in the nervous system. β-Amyloid precursor protein is axonally transported and accumulates in presynaptic terminals and growth cones A secreted form of β- APP (sAPPα) is released from neurons in response to electrical activity and may function in modulation of neuronal excitability, synaptic plasticity, neurite outgrowth, synaptogenesis, and cell survival. A signaling pathway involving guanosine 3',5'-cyclic monophosphate is activated by sAPPα and modulates the activities of potassium channels. N-methyl-D-aspartate receptors, and the transcription factor NFκB. Additional functions of β- APP may include modulation of cell adhesion and regulation of proliferation of nonneuronal cells. Alternative enzymatic processing of β-APP liberates Aβ, which has a propensity to form amyloid fibrils; Aβ can damage and kill neurons and increase their vulnerability to excitotoxicity. The mechanism involves generation of oxyradicals and impairment of membrane transport systems (e.g., ion-motive ATPases and glutamate and glucose transporters). Genetic mutations or age-related metabolic changes may promote neuronal degeneration in Alzheimer's disease by increasing production of Aβ and/or decreasing levels of neuroprotective sAPPα.
AB - Amyloid precursor protein (β-APP), the source of the fibrillogenic amyloid β-peptide (Aβ) that accumulates in the brain of victims of Alzheimer's disease, is a multifunctional protein that is widely expressed in the nervous system. β-Amyloid precursor protein is axonally transported and accumulates in presynaptic terminals and growth cones A secreted form of β- APP (sAPPα) is released from neurons in response to electrical activity and may function in modulation of neuronal excitability, synaptic plasticity, neurite outgrowth, synaptogenesis, and cell survival. A signaling pathway involving guanosine 3',5'-cyclic monophosphate is activated by sAPPα and modulates the activities of potassium channels. N-methyl-D-aspartate receptors, and the transcription factor NFκB. Additional functions of β- APP may include modulation of cell adhesion and regulation of proliferation of nonneuronal cells. Alternative enzymatic processing of β-APP liberates Aβ, which has a propensity to form amyloid fibrils; Aβ can damage and kill neurons and increase their vulnerability to excitotoxicity. The mechanism involves generation of oxyradicals and impairment of membrane transport systems (e.g., ion-motive ATPases and glutamate and glucose transporters). Genetic mutations or age-related metabolic changes may promote neuronal degeneration in Alzheimer's disease by increasing production of Aβ and/or decreasing levels of neuroprotective sAPPα.
UR - http://www.scopus.com/inward/record.url?scp=0030779677&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030779677&partnerID=8YFLogxK
M3 - Article
C2 - 9354812
AN - SCOPUS:0030779677
SN - 0031-9333
VL - 77
SP - 1081
EP - 1132
JO - Physiological Reviews
JF - Physiological Reviews
IS - 4
ER -